NeuBase Therapeutics, Inc. NBSE
0.38 +0.38
Day range unavailable
52-week range unavailable
Latest period ending Sep 30, 2022 · select a line to chart its full history
Annual cash flow
| Fiscal year | FY 2022 Sep 30, 2022 | FY 2021 Sep 30, 2021 | FY 2020 Sep 30, 2020 | FY 2019 Sep 30, 2019 | FY 2018 Sep 30, 2018 |
|---|---|---|---|---|---|
| 1.26M | 575.52K | 280.46K | 128.37K | 1.12M | |
| -257.02K | 42.34M | 33.11M | 13.60M | -86.26K | |
| -29.74M | 20.90M | 21.68M | 10.06M | -9.05M | |
| -471.71K | -1.44M | -716.82K | -455.20K | 528.04K | |
| 868 | 42.73M | 33.45M | 13.23M | 270.00K | |
| -257.88K | -390.57K | -349.79K | 509.92K | -356.26K | |
| -471.74K | -2.56M | -716.82K | -685.23K | 528.04K | |
| -30 | -25.01K | 0 | 0 | 0 | |
| -29.01M | -18.87M | -10.71M | -2.85M | -9.49M | |
| 2.90M | 3.70M | 5.19M | 8.96M | 1.02M |